2011
DOI: 10.1097/mcc.0b013e32834c9d87
|View full text |Cite
|
Sign up to set email alerts
|

Recent trends in antibiotic resistance in European ICUs

Abstract: As the epidemiology of antibiotic resistance in ICUs is rapidly changing toward more frequently occurring epidemics and endemicity of multi and panresistant Gram-negative pathogens, better infection control and improved diagnostics will become even more important than before.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
51
0
5

Year Published

2012
2012
2018
2018

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 81 publications
(57 citation statements)
references
References 72 publications
1
51
0
5
Order By: Relevance
“…The two other studies adopted a more defensive policy: all suspected VAP patients received broad-spectrum antibiotics, and antibiotic deescalation was hardly applied (27,33). These antibiotic strategies were very exceptional in the present study, as they still are in most other Dutch hospitals (34). Furthermore, patients with P. aeruginosa and MRSA colonization or infection were excluded in one study (27), although these microorganisms are well-known causes of VAP.…”
Section: Culturesmentioning
confidence: 83%
“…The two other studies adopted a more defensive policy: all suspected VAP patients received broad-spectrum antibiotics, and antibiotic deescalation was hardly applied (27,33). These antibiotic strategies were very exceptional in the present study, as they still are in most other Dutch hospitals (34). Furthermore, patients with P. aeruginosa and MRSA colonization or infection were excluded in one study (27), although these microorganisms are well-known causes of VAP.…”
Section: Culturesmentioning
confidence: 83%
“…Varios estudios de vigilancia a nivel mundial durante la década de 2000 han demostrado que del 20 al 80% de K. pneumoniae aislados fueron resistentes a los antibióticos de primera línea, incluyendo las cefalosporinas, fluoroquinolonas y aminoglucósidos (15,16) .…”
Section: Discussionunclassified
“…Combination therapy is recommended for neutropenic patients with sepsis, patients with risk factors for multidrug resistance (MDR) pathogen infections and patients with severe pneumonia (16). In the recent years, MDR is a growing problem in ICU worldwide (17)(18)(19). In the era of MDR pathogens, initially appropriate antibiotic therapy is more complicated that causes poor outcome (20)(21)(22)(23).…”
Section: De-escalation Therapymentioning
confidence: 99%